While it offers significant benefits, its also associated with certain side effects, particularly those affecting the digestive system
A comprehensive review of randomized controlled trials (RCTs) reveals that semaglutide significantly reduces body weight and the risk of cardiometabolic diseases like heart attack, stroke, and insulin resistance in adults with an overweight or obese body mass index (BMI)
Clinical Trials A small, early-phase randomized clinical trial at the University of North Carolina at Chapel Hill School of Medicine found that low-dose semaglutide significantly reduced alcohol cravings and total consumption in adults over 9 weeks
Because of this, providers monitor patients with risk factors
Mashlo 1mg Pre-filled Pen is administered as a once-weekly injection
For now, however, Michaelsen et al